KUSHKEVYCH, Ivan, Kristýna MARTÍNKOVÁ, Lenka MRÁKOVÁ, Francesco GIUDICI, Simone BALDI, David NOVÁK, Márió GAJDÁCS, Monika VÍTĚZOVÁ, Dani DORDEVIC, Amedeo AMEDEI a Simon K.-M. R. RITTMANN. Comparison of microbial communities and the profile of sulfate-reducing bacteria in patients with ulcerative colitis and their association with bowel diseases: a pilot study. Microbial Cell. Shared Science Publishers OG, 2024, roč. 11, č. 1, s. 79-89. ISSN 2311-2638. Dostupné z: https://dx.doi.org/10.15698/mic2024.03.817.
Další formáty:   BibTeX LaTeX RIS
Základní údaje
Originální název Comparison of microbial communities and the profile of sulfate-reducing bacteria in patients with ulcerative colitis and their association with bowel diseases: a pilot study
Autoři KUSHKEVYCH, Ivan (203 Česká republika, garant, domácí), Kristýna MARTÍNKOVÁ (203 Česká republika, domácí), Lenka MRÁKOVÁ (203 Česká republika, domácí), Francesco GIUDICI, Simone BALDI, David NOVÁK (203 Česká republika, domácí), Márió GAJDÁCS, Monika VÍTĚZOVÁ (203 Česká republika, domácí), Dani DORDEVIC, Amedeo AMEDEI a Simon K.-M. R. RITTMANN.
Vydání Microbial Cell, Shared Science Publishers OG, 2024, 2311-2638.
Další údaje
Originální jazyk angličtina
Typ výsledku Článek v odborném periodiku
Obor 10606 Microbiology
Stát vydavatele Rakousko
Utajení není předmětem státního či obchodního tajemství
WWW URL
Impakt faktor Impact factor: 4.600 v roce 2022
Organizační jednotka Přírodovědecká fakulta
Doi http://dx.doi.org/10.15698/mic2024.03.817
UT WoS 001187090800001
Klíčová slova anglicky gut microbiota; ulcerative colitis; gut dysbiosis; sulfate-reducing bacteria; inflammatory bowel disease; 16S rRNA gene sequencing
Štítky rivok
Příznaky Mezinárodní význam, Recenzováno
Změnil Změnila: Mgr. Marie Šípková, DiS., učo 437722. Změněno: 5. 4. 2024 09:46.
Anotace
Considerable evidence has accumulated regarding the molecular relationship between gut microbiota (GM) composition and the onset (clinical presentation and prognosis of ulcerative colitis (UC)). In addition, it is well documented that short-chain fatty acid (SCFA)-producing bacteria may play a fundamental role in maintaining an anti-inflammatory intestinal homeostasis, but sulfate- and sulfite reducing bacteria may be responsible for the production of toxic metabolites, such as hydrogen sulfide and acetate. Hence, the present study aimed to assess the GM composition – focusing on sulfate-reducing bacteria (SRB) – in patients with severe, severe-active and moderate UC. Each one of the six enrolled patients provided two stool samples in the following way: one sample was cultivated in a modified SRB-medium before 16S rRNA sequencing and the other was not cultivated. Comparative phylogenetic analysis was conducted on each sample. Percentage of detected gut microbial genera showed considerable variation based on the patients’ disease severity and cultivation in the SRB medium. In detail, samples without cultivation from patients with moderate UC showed a high abundance of the genera Bacteroides, Bifidobacterium and Ruminococcus, but after SRB cultivation, the dominant genera were Bacteroides, Klebsiella and Bilophila. On the other hand, before SRB cultivation, the main represented genera in patients with severe UC were Escherichia-Shigella, Proteus, Methanothermobacter and Methanobacterium. However, after incubation in the SRB medium Bacteroides, Proteus, Alistipes and Lachnoclostridium were predominant. Information regarding GM compositional changes in UC patients may aid the development of novel therapeutic strategies (e.g., probiotic preparations containing specific bacterial strains) to counteract the mechanisms of virulence of harmful bacteria and the subsequent inflammatory response that is closely related to the pathogenesis of inflammatory bowel diseases.
Návaznosti
MUNI/A/1280/2022, interní kód MUNázev: Podpora výzkumné činnosti studentů Mikrobiologie 3
Investor: Masarykova univerzita, Podpora výzkumné činnosti studentů Mikrobiologie 3
VytisknoutZobrazeno: 23. 6. 2024 21:07